Viewing StudyNCT04649112

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 3:28 PM
Last Modification Date: 2024-10-26 @ 1:50 PM
Study NCT ID: NCT04649112
Status: COMPLETED
Last Update Posted: 2022-11-09
First Post: 2020-11-24
Brief Title: Dose-escalation Study of Safety of PBCAR19B in Participants With CD19-expressing Malignancies
Sponsor: Precision BioSciences Inc
Organization: Precision BioSciences Inc
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Hematologic Malignancy
CD19 Expressing Malignancies
Keywords: